Skip to content

Tagdoctor

IUD may increase breast cancer risk in certain women.

A new study has found that a specific intrauterine device (IUD) is associated with a greater risk of breast cancer, but not endometrial, ovarian, pancreatic, or lung cancers. The researchers examined data from over 93,000 women in Finland who had used the LNG-IUS to treat their menorrhagia. The women ranged in age from 30 to 49 years. The breast cancer rate for the group using the system for menorrhagia control was approximately 19% higher than the breast cancer rate for the general population. No increase in uterine cancer or ovarian, pancreatic, or lung cancers was seen with IUD use. Other factors, beyond the IUD use, could also be at play, especially factors related to the menorrhagia, so a direct link between IUD use and cancer will need to be proven by additional research.

Thoughts health innovators?

Review of ADHD drug approvals highlights gaps between approval process, long-term safety assessment.

Review of ADHD drug approvals highlights gaps between approval process, long-term safety assessment. Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events. The study highlights gaps in how the long-term safety of drugs intended for chronic use in children is assessed as part of the FDA approval process.

Thoughts health innovators?

Healthinnovations on the BBC World panel on the Danish ‘Fat Tax’ [unedited]

We know that obesity kills, we know that obesity costs the global economy billions, what we don’t know is how to sustainably treat obesity to bring the former points to … Continue Reading Healthinnovations on the BBC World panel on the Danish ‘Fat Tax’ [unedited]